Learn how Pfizer uses the Island to protect sensitive web applications and cut costs without overhauling its legacy systems.
“Our use case was around protecting some sensitive web applications. Then we started realizing through conversations with Island just how many different use cases there were.”— Brian A. Coleman, Head of Insider Risk, Digital Forensics, and Information Security, Pfizer
As a global biopharmaceutical giant, Pfizer faces the challenge of protecting sensitive web applications and critical data across a sprawling, globally distributed workforce.
To maintain productivity while meeting stringent security demands, Pfizer turned to a solution that seamlessly integrated into its operations: the Island Enterprise Browser.
Today, Island seamlessly integrates security and visibility into Pfizer’s legacy applications and systems, without missing a beat in workforce efficiency.
Here's how Island is transforming Pfizer's approach to global security.
Pfizer needed to protect sensitive web applications without overhauling its legacy systems – systems which would be too difficult to modify or secure without extensive effort and expense.
Pfizer’s Head of Insider Risk, Digital Forensics, and Information Security, Brian A. Coleman, realized that while traditional consumer browsers are “free,” they lack the necessary security and control required for enterprise environments.
Then he discovered Island’s Enterprise Browser. Island uniquely layers security over existing applications with minimal disruption – in stark contrast to both unsecured consumer browsers as well as to most security solutions on the market, which demand significant re-coding.
So, Pfizer made the leap – eventually making Island a core component of their global IT security strategy.
Island seamlessly integrated into Pfizer’s workflow, maintaining user experience while adding significant security enhancements. “You can apply different policies to different groups of users,” says Coleman. “If you don’t have great RBAC for a legacy application, you can now create RBAC through the browser.”
Initially focused on securing sensitive web applications, Pfizer quickly realized Island’s broader potential—from enabling secure BYOD policies to replacing costly legacy systems like VDI. Today, the Island Enterprise Browser acts as an essential "last-mile" security tool for Pfizer.
“You can enforce two-factor authentication, use integrations with password management solutions. There’s a lot of security capabilities that became apparent to us.”
What truly set Island apart for Pfizer was its ability to meet three critical needs across their organization: enhanced security, real-time visibility, and improved data control—all without disrupting user workflows.
Armed with these key benefits and more, Pfizer has now deployed Island globally, ensuring seamless functionality for its complex applications while upholding strong security across its distributed workforce.
Here are just a few of the benefits Pfizer is already seeing from implementing the Island Enterprise Browser:
The Island Enterprise Browser has changed the game for Pfizer, a global pharma powerhouse. More than a browser, Island is a security platform built for the enterprise, providing Pfizer with granular control, visibility, and integration into their existing systems without compromising productivity.
And Island isn't just for large enterprises. Any organization with a globally distributed workforce, legacy systems, or critical web applications can benefit from the granular, seamless controls Island has to offer. Island is more than just a browser—it’s the last-mile security solution that delivers both productivity and peace of mind.
“People have to give it a real look,” says Coleman. Despite initial skepticism about paying for a browser, he says, “When you start looking at potential savings and improved security, you’ll see the value.”
As Head of Content and Communications, Jess oversees editorial, social media, and customer content at Island. Before Island, Jess stood up content functions at LASSO and Marpipe, and managed editorial and EMEA content at Fastly. Jess spent the first 15 years of her career as a copywriter and creative director, executing breakthrough work for B2C brands like Eggo, Rice Krispies, Blue Cross, Cottonelle, and McDonald’s.